In contrast with the metastatic setting, programmed death-ligand-1 (PD-L1) expression seemed to predict pCR in pre-treated early BC.15,20 TILs are known to be prognostic in TNBC and their potential value has been investigated in the context of immunotherapy strategies. This evidence concerns the gene CD274 and breast cancer.